Skip to content
Government policy impacting biotech—including drug price controls, pharmacy benefit managers (PBMs), accelerated approval, and support for new antibiotics—received a public airing this week when […]
People with an aggressive blood cancer that does not respond to treatments have been given new hope for a cure after Syndax Pharmaceuticals’ experimental
Syndax’s experimental drug signals new chance at life for a third of AML patients Read More »
Moderna CEO Stéphane Bancel testified on Capitol Hill yesterday during a hearing that one U.S. Senator compared to a “show trial” and “public shaming”
Moderna hearing on Capitol Hill is ‘more like a show trial,’ says U.S. Senator Read More »
AI is poised to transform drug discovery—and this film competition will show how. While the use of generative artificial intelligence (AI) to develop new
Biotech company seeks creative scientific storytellers for Docuthon film competition Read More »
It’s World Water Day, and the U.N. encourages everyone to take action in any way possible. And biotechnology has the potential to make a
It’s World Water Day, and biotech can join in the efforts for cleaner water Read More »
As Moderna CEO Stéphane Bancel heads to Capitol Hill to testify before the Health, Education, Labor, and Pensions (HELP) Committee, experts are watching to
To protect innovation, we need to protect Bayh-Dole, says one expert Read More »
International Day of Forests is a chance to acknowledge the importance of forests in the global ecosystem. Since 2013, the United Nations has celebrated
International Day of Forests: ‘On the cusp of a green revolution in forestry’ Read More »
Despite the existence of the bioengineered label on foods for over a year, consumer behavior regarding food choices has remained largely unchanged. Starting January
Consumer habits largely unaffected by foods labeled for bioengineered ingredients Read More »
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers
4 questions with Moderna President Stephen Hoge Read More »
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
